基于医院与社区比较的中医非药物疗法治疗原发性高血压随机对照试验的现状与特征分析*

doi:10.3969/j.issn.2095-6606.2021.01.003

摘要/Abstract

摘要： 目的比较医院与社区卫生机构开展的中医非药物疗法治疗原发性高血压随机对照试验(RCT)的现状与特征。方法系统检索中国知网(CNKI)、维普资讯中文期刊数据库(VIP)和万方数据库(WANFANG DATA),纳入2013—2018年发表的中医非药物疗法治疗原发性高血压的RCT期刊文献,分为医院组与社区组进行比较分析。结果共纳入85项RCT,其中医院组66项(77.6%),社区组19项(22.4%)。医院组RCT分布于22个省(自治区、直辖市),社区组RCT分布于8个省(自治区、直辖市)。2组样本量比较差异无统计学意义(P>0.05)。共涉及11类中医非药物疗法,其中医院组涉及10类,社区组涉及7类。社区组报告随访比例高于医院组(P<0.05)。社区组观测生存质量、其他指标的比例高于医院组(P<0.05);社区组仅用有效率作为血压控制结局指标的比例高于医院组(P<0.05)。2组核心期刊发表比例比较差异无统计学意义(P>0.05),社区组获得科研基金支持的比例高于医院组(P<0.05)。结论医院、社区卫生机构在RCT文献发表数量、地域分布、涉及的中医非药物疗法种类、随访、结局指标的选取及科研基金支持等方面有所不同,有待进一步研究。应进一步重视社区卫生机构开展RCT的作用,提升其科研水平。

关键词: 医院, 社区, 随机对照试验, 原发性高血压, 中医, 非药物疗法

Abstract: Objective To analyze the situation and features of randomized controlled trials (RCTs) about the TCM non-drug therapies for essential hypertension (ESH) conducted in hospitals and community health centers. Methods CNKI, CQVIP and Wanfang databases were searched, and then we included RCTs about TCM non-drug therapies on ESH conducted in hospitals and community health centers from 2013 to 2018, and divided them into the hospital group and the community group. Results 85 RCTs were included, of which 66 (77.6%) were conducted in hospitals and 19 (22.4%) were carried out in communities. The RCTs of the hospital group were distributed in 22 provinces, autonomous regions and municipalities, and the RCTs of the community group were distributed in 8 provinces, autonomous regions and municipalities. The sample size had no statistically significant differences between the two groups (P>0.05). A total of 11 types of TCM non-drug therapies were involved in 2 groups. The hospital group involved 10 types and the community group involved 7 types. The RCTs' ratio that reported follow-up was higher in the community group than in the hospital group (P< 0.05). The proportion of RCTs that reported quality of life and other outcomes was higher in the community group than in the hospital group (P<0.05). The proportion of RCTs with only effective rate as the outcome of blood pressure control was higher in the community group than in the hospital group (P<0.05). There was no significant difference in the ratio of RCTs published in core journals and non-core journals between the two groups (P>0.05). The proportion of RCTs supported by research funds was higher in the community group than in hospital group (P<0.05). Conclusions Hospitals and community differ in the number of RCTs published, geographical distribution, types of TCM non-drug therapies involved, follow-up, selection of outcomes and research funding support, etc. We should pay more attention to the role of RCTs conducted in community, so as to enhance its research.

Key words: hospital, community, randomized controlled trial, essential hypertension, TCM, non-drug therapy

中图分类号:

R259

李玉琦, 梁士兵, 姜厚望, 尚亚西, 陈亚飞, 李静, 乔舒昱, 刘建平. 基于医院与社区比较的中医非药物疗法治疗原发性高血压随机对照试验的现状与特征分析^*[J]. 现代中医临床, 2021, 28(1): 11-17.

Li Yuqi, Liang Shibing, Jiang Houwang, Shang Yaxi, Chen Yafei, Li Jing, Qiao Shuyu, Liu Jianping. Current situation and features of randomized controlled trials about Chinese medicine non-drug therapies on essential hypertension based on comparison between general hospitals and community health centers^*[J]. Modern Chinese Clinical Medicine, 2021, 28(1): 11-17.

参考文献

[1] WANG Z W,ZUO C,ZHANG L F,et al. Status of hypertension in China[J]. Circulation, 2018,137(22): 2344-2356.
[2] BOWLING C B, DAVIS B R, LUCIANO A,et al. Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: an observational analysis of ALLHAT[J]. Journal of Clinical Hypertension (Greenwich, Conn.),2019,21(4):451-459.
[3] MUSINI V M,GUEYFFIER F,PUIL L,et al. Pharmacotherapy for hypertension in adults aged 18 to 59 years[J]. Cochrane Database of Systematic Reviews,2020,26(1). e12769.
[4] 冯芮华,王增武,王小万,等.高血压社区规范化管理中常用抗高血压药物的成本-效果研究[J].中国全科医学,2016,19(1):92-95.
[5] 王丹.社区老年原发性高血压患者药物治疗依从性现状及其影响因素分析[J].中国实用医药,2018,13(20):188-190.
[6] YANG X C,ZHAO H,WANG J,et al. Chinese massage (tuina) for the treatment of essential hypertension: a systematic review and meta-analysis[J].Complementary Therapies in Medicine,2014,22(3):541-548.
[7] XIONG X J,LIU W,YANG X C. Moxibustion for essential hypertension[J]. Complementary Therapies in Medicine,2014,22(1):187-195.
[8] ZHONG D, LI J, YANG H,et al. Tai chi for essential hypertension: a systematic review of randomized controlled trials[J]. Curr Hypertens Rep,2020,22(3):1-12.
[9] 陈晓敏,邵南齐,马霄,等.中医非药物疗法治疗原发性高血压 Meta分析及系统评价[J].吉林中医药,2016,36(9):887-890.
[10] CHEN H,SHEN F E,TAN X D,et al . Efficacy and safety of acupuncture for essential hypertension: a meta-Analysis[J].Med Sci Monit,2018,24(8):2946-2969.
[11] 《国务院关于发展城市社区卫生服务的指导意见》配套文件权威专家解读——《关于加强城市卫生人才队伍建设的指导意见》[J].中国全科医学,2007,10(10):857.
[12] 《国务院关于发展城市社区卫生服务的指导意见》配套文件权威专家解读——《关于城市社区卫生服务中充分发挥中医药作用的意见》[J].中国全科医学,2007,10(6):511-512.
[13] 中华人民共和国卫生部.医疗机构基本标准(试行):卫医发[1994]30号[EB/OL](1994-09-02)[2020-10-22]. http://www.nhc.gov.cn/wjw/xinx/xinxi.shtml.
[14] 霍芸,韦艳碧.疤痕灸治疗原发性高血压145例临床观察[J].光明中医,2017,32(20):2928-2930.
[15] 谢波,林亚平.针刺治疗阴虚阳亢型原发性高血压病临床疗效观察[J].中国针灸,2014,34(6):547-550.
[16] 邹艳,吕小笑,罗志平.曲池穴捻转补泻法治疗原发性高血压疗效观察[J].上海针灸杂志,2015,34(9):52-54.
[17] 洪海裕,陈奕伸,洪仲思,等.电极、激光刺激穴位配合音乐治疗原发性1级高血压病临床研究[J].中国针灸,2014,34(7):713-716.
[18] 黄梅香,肖瑶.广州市天河区社区卫生服务中心中医适宜技术应用与推广现状调查[J].中国初级卫生保健,2019,33(9):33-35.
[19] 唐虹,刘继洪,陈健英,等.耳针疗法结合社区干预对高血压病的防治价值评估报告[J].针灸临床杂志,2015,31(7):15-20.
[20] CARR S A,DAVIS R,SPENCER D,et al. Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in alzheimer disease clinical trials[J]. Alzhmer Disease & Associated Disorders, 2010,24(2):165-170.
[21] 李裕聪,梁瑞琼,邱鸿钟.中医“治未病”服务的现状、问题与政策分析[J].中国卫生事业管理,2019,36(5):351-353.
[22] 孙立奇,张涛,李书婷,等.杭州市居民对社区中医药服务的满意度调查[J].卫生软科学,2018,32(8):78-81.
[23] 石云,施晓琳,贾杨,等.上海社区中医适宜技术使用现状与政策建议[J].中医药管理杂志,2019,27(18):200-202.
[24] 张晗,熊巨洋,沈晓,等.石家庄市中医药服务综合改革效果DEA评价[J].医学与社会,2018,31(11):8-10,14.
[25] 刘玉莲,章国平,徐伟民,等.宁波市基层中医药发展的现状探讨[J].中国农村卫生事业管理,2018,38(7):901-903.
[26] 彭远兰,简伟,甄真,等.重庆市南岸区中医药适宜技术社区推广与应用方法的影响因素[J].临床医药文献电子杂志,2018,5(40):59,62.
[27] 沈文娟,刘建平,吴效科,等.中医临床试验研究的现状及提升策略[J].中医药学报,2016, 44(5):1-4.
[28] 沈文娟,吴效科,王桂媛,等.中医临床试验研究方案设计常见问题及解决策略[J].中医药学报,2015,43(4):1-4.
[29] 李欣霖,张雅静,刘建平,等.考虑患者偏好的部分随机临床试验在中医非药物疗法疗效评价中的设计与应用[J].中医杂志,2016,57(20):1750-1753,1767.
[30] 国家卫生和计划生育委员会.涉及人的生物医学研究伦理审查办法[EB/OL].(2016-10-12)[2017-10-16].http://www.nhc.gov.cn/fzs/s3576/201610/84b33b81d8e747eaaf048f68b174f829.shtml.
[31] 规划发展与信息化司.2019年我国卫生健康事业发展统计公报[EB/OL]. (2020-06-06)[2020-10-22].http://www.nhc.gov.cn/guihuaxxs/s10748/202006/ebfe31f24cc145b198dd730603ec4442.shtml.
[32] GHARIPOUR M,KELISHADI R,KHOSRAVI A,et al. The impact of a community trial on the pharmacological treatment in the individuals with the metabolic syndrome: findings from the Isfahan Healthy Heart Program,2001—2007[J]. Archives of Medical Science,2012,8(6):1009-1017.
[33] ZENG Q Z,HE Y L,SHI Z Y,et al. A community-based controlled trial of a comprehensive psychological intervention for community residents with diabetes or hypertension[J]. Shanghai Archives of Psychiatry,2016,28(2):72-85.
[34] LI H,WEI X,WONG M C,et al. A comparison of the quality of hypertension management in primary care between Shanghai and Shenzhen: a cohort study of 3 196 patients[J].Medicine (Baltimore), 2015,94(5):455.
[35] 黄蓓.上海加强社区中医药服务[J].中医药管理杂志,2019,27(4):34.